Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tryton launches branched stent in EU

This article was originally published in Clinica

Executive Summary

Tryton Medical has launched its novel Side Branch Stent System onto the European market. Intended to treat atherosclerotic lesions at the site of a bifurcation, the cobalt chromium stent is designed to be implanted along with a conventional drug-eluting stent. The system is now on sale in the Netherlands, where it will be distributed by TOP Medical (Nuth, the Netherlands). Further European launches will follow in the coming months. The Research Triangle Park, North Carolina-based firm will also start a study evaluating the device in real-life practice "in the coming weeks." Around 20% of patients treated for coronary artery disease are treated for bifurcated lesions. The stent was CE marked in February (see Clinica No 1293, p 26); it is not approved in the US.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT043096

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel